Vinpocetine for Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if adding vinpocetine to standard levodopa treatment can help Parkinson's disease patients. It aims to see if this combination improves symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 50 years old
- You have been diagnosed with Parkinson's disease
- You are already taking levodopa for Parkinson's
- You are not pregnant or breastfeeding, and use effective birth control if needed
- You do not have heart disease, bleeding disorders, active cancer, or a history of brain surgery for Parkinson's
- You are not taking anti-inflammatory drugs or addicted to alcohol or drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
This study tests a treatment called ischemic conditioning, which uses brief blood-flow restriction to improve blood vessel health, to see if it can help with Parkinson's disease symptoms. It may help improve blood flow and potentially ease some motor and non-motor symptoms.
This early-stage trial tests a new treatment where specialized cells are injected directly into the brain. It is for people with advanced Parkinson's who have been on levodopa for a while and experience 'off' periods or involuntary movements.
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.